Latin America Stem Cell Market Research Report - Segmented By Mode Of Treatment, Applications, Technology, Type & By Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis, Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029)

Updated On: June, 2024
ID: 1026
Pages: 133

Latin American Stem Cell Market Size (2023 to 2028)

The Latin American Stem Cell Market size is estimated to be growing at a CAGR of 10.9% during the forecast period. The market size is predicted to be worth USD 2581.55 million by 2028 from USD 1538.94 million in 2023.

Factors such as the growing geriatric population and incidences of chronic diseases such as cardiovascular, leukemia, cancer diseases, neurodegenerative disorders, and gastrointestinal diseases are majorly propelling the growth of the Latin American stem cell market. Strong support from government and private agencies is ascribed to boost up the demand of the market. A rising aging population and chronic diseases are key factors responsible for driving the stem cells market in this part of the world. In clinical research, to examine drug effectiveness, stem cells are used effectively, propelling the market's growth. The rise in the number of people suffering from chronic illnesses is an important factor for companies to expand the stem cell market in this region. The development of induced pluripotent stem cell lines also prompts demand for the stem cell market in this region.

However, the cost of stem cell therapies and research related to stem cells is restraining the demand for the market in this region.

This research report on the Latin American stem cell market has been segmented and sub-segmented into the following categories:

By Treatment mode:

  • Allogeneic
  • Autologous

By Cells Type: 

  • Adult stem cells
  • Induced pluripotent stem cells
  • Human embryonic stem cells
  • Others

By Technology: 

  • Cell acquisition
  • Cell production
  • Cryopreservation
  • Other sub-segments

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Geographically, the Mexican stem cell market is the most lucrative regional market in Latin America. An increase in the investment in research and development on stem cells is likely to bolster the market's demand. Developing countries like Argentina are esteemed to have a significant growth rate in the forecast period.


A few of the promising companies in the Latin American stem cell market profiled in this report are Athersys, StemCells Inc, Cryo-Cell International, Geron Corporation, Mesoblast Ltd, Aastrom Biosciences Inc, Celgene Corporation, Invitrogen and Cytori Therapeutics Inc.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample